TSS
ABMD

Two Sigma Securities’s Abiomed Inc ABMD Stock Holding History

Two Sigma Securities’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-800
Closed -$250K – 2072
2021
Q2 		$250K Buy
+800
New +$245K 0.01% 1129
2020
Q1 		– Sell
-2,700
Closed -$461K – 2529
2019
Q4 		$461K Buy
2,700
+1,300
+93% +$241K ﹤0.01% 1489
2019
Q3 		$249K Buy
1,400
+400
+40% +$86.5K ﹤0.01% 1704
2019
Q2 		$260K Buy
+1,000
New +$265K ﹤0.01% 1538

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Securities's ABMD Position: Q4 2022 in Review

Two Sigma Securities sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,177 shares — an estimated $535K sold.

Two Sigma Securities first reported a position in ABMD in Q4 2017 and held it in 6 quarters. The position peaked at $535K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Two Sigma Securities reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 2,177 Abiomed Inc shares in Q4 2022, an estimated $535K.
  • Two Sigma Securities first reported a position in Abiomed Inc in Q4 2017 and held it in 6 quarters.
  • Two Sigma Securities's Abiomed Inc position peaked at $535K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.